CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
Venus Vivadevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03831477
NCT03831477N/ACompleted
CompareCT.gov

Clinical Evaluation of the Safety and Performance of Fractional Radiofrequency for the Treatment and Reduction of Facial Wrinkles

Venus Concept·interventional·Posted Feb 5, 2019·Updated Sep 6, 2023

In Brief

A clinical study evaluating Venus Viva for Rhytides and Wrinkle. Completed, enrolled 15 participants across 1 site.

Detailed Summary

Prospective, single centre, evaluator-blind study of the safety and performance of fractional radiofrequency (RF) for the treatment and reduction of facial wrinkles.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRhytides, Wrinkle
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedFeb 5, 2019
Enrollment StartDec 12, 2018
Primary CompletionAug 9, 2019
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 7.4 years ago

Interventions

Venus Vivadevice

The Venus Viva™ is a non-invasive medical aesthetic device, intended for use in dermatologic and general surgical procedures, requiring ablation and resurfacing of the skin, using the Viva applicator.